Calculate quercetin dose by goal. Flavonoid found in onions, apples, capers. Three main use cases: allergies (mast cell stabilizer), senolytic protocols (with fisetin or dasatinib), cardiovascular / anti-inflammatory. Absorption is poor — form matters. Math, not medical advice.
Your situation
500
mg quercetin / dose, twice daily
mg quercetin / dose, twice daily
Use cases and evidence
- Allergies: mast cell stabilizer. Mechanism plausible; clinical evidence modest. Pair with vitamin C + bromelain.
- Cardiovascular: modest BP reduction (3-4 mmHg systolic in hypertensive subjects). Anti-inflammatory effects on endothelium.
- Senolytic protocol: Mayo Clinic Kirkland protocol pairs quercetin 1000 mg + dasatinib 100 mg for 2 consecutive days/month. Currently in human trials. Quercetin + fisetin is the “natural” version some use.
- Immune / antiviral: in vitro effects against multiple viruses. Clinical efficacy thin. COVID-era hype unsupported by RCTs.
- Exercise: small endurance benefit (about 3% VO2max increase in some studies). Probably not noticeable in well-trained athletes.
Senolytic stack (advanced — discuss with clinician)
- “Hit and run” protocol: senolytics target senescent cells; long-term daily dosing not required (and potentially counterproductive).
- Kirkland Mayo Clinic protocol: dasatinib 100 mg + quercetin 1000 mg for 2 consecutive days/month. RX dasatinib required — clinical only.
- “Natural” alternative: fisetin 1000 mg/day for 2 days, monthly. Or quercetin 1000 mg + fisetin 500 mg same protocol.
- This is experimental. Human evidence is preliminary (small trials in diabetic kidney disease, idiopathic pulmonary fibrosis). Self-experimentation territory.
Interactions and cautions
- Warfarin / DOACs: quercetin inhibits CYP3A4 + may affect bleeding risk. Monitor INR / consult prescriber.
- BP medications: additive BP lowering. Monitor BP.
- Thyroid hormone: quercetin may interfere with thyroid hormone synthesis (animal data). Caution in hypothyroidism.
- Ciclosporin / tacrolimus: quercetin affects CYP3A4 metabolism of these drugs — concentration changes possible. Coordinate with transplant team.
- Chemotherapy: some chemo agents are CYP3A4 substrates. Quercetin can alter levels. Discuss with oncologist.